Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -67.58% is 32% below its 5-year average of -51.33%, near the low end of its 5-year range (-82.68%–-21.78%).
As of the fiscal period ended Tuesday, June 30, 2026. 6.90% above its 12-month average of -72.59%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -67.58%.
RETURN ON INVESTED CAPITAL (ROIC)
-67.58%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-72.59%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-61.66%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-51.33%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
+6.90%
CURRENT VS 3Y AVG
-9.61%
CURRENT VS 5Y AVG
-31.67%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-35.64%
median of 838 covered companies
CURRENT VS SECTOR MEDIAN
-89.60%
vs the sector median at left
Sana Biotechnology, Inc.
Market Cap
$780.61M
Return on Invested Capital (ROIC)
-67.58%
TTM Avg
-72.59%
3Y Avg
-61.66%
5Y Avg
-51.33%
Market Cap
$782.66M
Return on Invested Capital (ROIC)
-8.34%
TTM Avg
-22.82%
3Y Avg
-51.67%
5Y Avg
-50.32%
Market Cap
$778.22M
Return on Invested Capital (ROIC)
6.30%
TTM Avg
-3.00%
3Y Avg
1.90%
5Y Avg
3.29%
Market Cap
$785.58M
Return on Invested Capital (ROIC)
-0.26%
TTM Avg
4.90%
3Y Avg
-0.53%
5Y Avg
1.15%
Market Cap
$775.12M
Return on Invested Capital (ROIC)
-23.16%
TTM Avg
-53.28%
3Y Avg
-63.06%
5Y Avg
-59.41%
Market Cap
$794.92M
Return on Invested Capital (ROIC)
-9.77%
TTM Avg
8.57%
3Y Avg
-11.39%
5Y Avg
-51.99%
Market Cap
$765.90M
Return on Invested Capital (ROIC)
-42.83%
TTM Avg
-51.53%
3Y Avg
-51.53%
5Y Avg
-51.53%
Market Cap
$759.16M
Return on Invested Capital (ROIC)
3.29%
TTM Avg
2.60%
3Y Avg
-15.46%
5Y Avg
-9.88%
Market Cap
$802.43M
Return on Invested Capital (ROIC)
9.20%
TTM Avg
13.08%
3Y Avg
19.17%
5Y Avg
23.78%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Sana Biotechnology, Inc. (SANA) | $780.61M | -67.58% | -72.59% | -61.66% | -51.33% |
| Geron Corporation (GERN)vs › | $782.66M | -8.34% | -22.82% | -51.67% | -50.32% |
| Varex Imaging Corporation (VREX)vs › | $778.22M | 6.30% | -3.00% | 1.90% | 3.29% |
| AdaptHealth Corp. (AHCO)vs › | $785.58M | -0.26% | 4.90% | -0.53% | 1.15% |
| Lexicon Pharmaceuticals, Inc. (LXRX)vs › | $775.12M | -23.16% | -53.28% | -63.06% | -59.41% |
| Gyre Therapeutics, Inc. (GYRE)vs › | $794.92M | -9.77% | 8.57% | -11.39% | -51.99% |
| Attovia Therapeutics, Inc. (ATTO)vs › | $765.90M | -42.83% | -51.53% | -51.53% | -51.53% |
| Mesa Laboratories, Inc. (MLAB)vs › | $759.16M | 3.29% | 2.60% | -15.46% | -9.88% |
| InMode Ltd. (INMD)vs › | $802.43M | 9.20% | 13.08% | 19.17% | 23.78% |
| Jade Biosciences, Inc. (JBIO)vs › | $804.96M | -37.39% | -65.53% | -61.64% | -93.68% |
ROIC
-67.6%
ROE
-137.0%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -67.58% |
| 2026-03-31 | -82.68% |
| 2025-12-31 | -74.02% |
| 2025-09-30 | -60.01% |
| 2025-06-30 | -78.68% |
| 2025-03-31 | -51.57% |
| 2024-12-31 | -59.86% |
| 2024-09-30 | -60.98% |
| 2024-06-30 | -44.53% |
| 2024-03-31 | -50.89% |
| 2023-12-31 | -58.53% |
| 2023-09-30 | -50.34% |
| 2023-06-30 | -61.90% |
| 2023-03-31 | -50.44% |
| 2022-12-31 | -38.32% |
| 2022-09-30 | -38.56% |
| 2022-06-30 | -34.25% |
| 2022-03-31 | -21.78% |
| 2021-12-31 | -34.65% |
| 2021-09-30 | -31.47% |
| 2021-06-30 | -26.88% |
| 2021-03-31 | -34.16% |
| 2020-12-31 | -40.95% |
| 2020-09-30 | -29.40% |
